<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2020-10-07" version="198">
<accession>P48551</accession>
<accession>A8KAJ4</accession>
<accession>D3DSE8</accession>
<accession>D3DSE9</accession>
<accession>Q15467</accession>
<accession>Q6FHD7</accession>
<name>INAR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interferon alpha/beta receptor 2</fullName>
<shortName>IFN-R-2</shortName>
<shortName>IFN-alpha binding protein</shortName>
<shortName>IFN-alpha/beta receptor 2</shortName>
</recommendedName>
<alternativeName>
<fullName>Interferon alpha binding protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Type I interferon receptor 2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IFNAR2</name>
<name type="synonym">IFNABR</name>
<name type="synonym">IFNARB</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Cell" volume="77" first="391" last="400">
<title>The human interferon alpha/beta receptor: characterization and molecular cloning.</title>
<authorList>
<person name="Novick D."/>
<person name="Cohen B."/>
<person name="Rubinstein M."/>
</authorList>
<dbReference type="PubMed" id="8181059"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90154-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>GLYCOSYLATION AT ASN-87 AND ASN-192</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH JAK1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT VAL-10</scope>
<source>
<tissue>Monocyte</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="5100" last="5108">
<title>Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster.</title>
<authorList>
<person name="Lutfalla G."/>
<person name="Holland S.J."/>
<person name="Cinato E."/>
<person name="Monneron D."/>
<person name="Reboul J."/>
<person name="Rogers N.C."/>
<person name="Smith J.M."/>
<person name="Stark G.R."/>
<person name="Gardiner K."/>
<person name="Mogensen K.E."/>
<person name="Kerr I.M."/>
<person name="Uze G."/>
</authorList>
<dbReference type="PubMed" id="7588638"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1995.tb00192.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Lymphoblastoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="21606" last="21611">
<title>Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling.</title>
<authorList>
<person name="Domanski P."/>
<person name="Witte M."/>
<person name="Kellum M."/>
<person name="Rubinstein M."/>
<person name="Hackett R."/>
<person name="Pitha P."/>
<person name="Colamonici O.R."/>
</authorList>
<dbReference type="PubMed" id="7665574"/>
<dbReference type="DOI" id="10.1074/jbc.270.37.21606"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<source>
<tissue>Myeloma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="J. Leukoc. Biol." volume="57" first="712" last="718">
<title>Soluble and membrane-anchored forms of the human IFN-alpha/beta receptor.</title>
<authorList>
<person name="Novick D."/>
<person name="Cohen B."/>
<person name="Tal N."/>
<person name="Rubinstein M."/>
</authorList>
<dbReference type="PubMed" id="7759950"/>
<dbReference type="DOI" id="10.1002/jlb.57.5.712"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH JAK1</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
<scope>VARIANT VAL-10</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="1996-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Cohen B."/>
<person name="Kim S.H."/>
<person name="Novick D."/>
<person name="Rubinstein M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT VAL-10</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2004-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-8; VAL-10 AND VAL-196</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Nature" volume="405" first="311" last="319">
<title>The DNA sequence of human chromosome 21.</title>
<authorList>
<person name="Hattori M."/>
<person name="Fujiyama A."/>
<person name="Taylor T.D."/>
<person name="Watanabe H."/>
<person name="Yada T."/>
<person name="Park H.-S."/>
<person name="Toyoda A."/>
<person name="Ishii K."/>
<person name="Totoki Y."/>
<person name="Choi D.-K."/>
<person name="Groner Y."/>
<person name="Soeda E."/>
<person name="Ohki M."/>
<person name="Takagi T."/>
<person name="Sakaki Y."/>
<person name="Taudien S."/>
<person name="Blechschmidt K."/>
<person name="Polley A."/>
<person name="Menzel U."/>
<person name="Delabar J."/>
<person name="Kumpf K."/>
<person name="Lehmann R."/>
<person name="Patterson D."/>
<person name="Reichwald K."/>
<person name="Rump A."/>
<person name="Schillhabel M."/>
<person name="Schudy A."/>
<person name="Zimmermann W."/>
<person name="Rosenthal A."/>
<person name="Kudoh J."/>
<person name="Shibuya K."/>
<person name="Kawasaki K."/>
<person name="Asakawa S."/>
<person name="Shintani A."/>
<person name="Sasaki T."/>
<person name="Nagamine K."/>
<person name="Mitsuyama S."/>
<person name="Antonarakis S.E."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Nordsiek G."/>
<person name="Hornischer K."/>
<person name="Brandt P."/>
<person name="Scharfe M."/>
<person name="Schoen O."/>
<person name="Desario A."/>
<person name="Reichelt J."/>
<person name="Kauer G."/>
<person name="Bloecker H."/>
<person name="Ramser J."/>
<person name="Beck A."/>
<person name="Klages S."/>
<person name="Hennig S."/>
<person name="Riesselmann L."/>
<person name="Dagand E."/>
<person name="Wehrmeyer S."/>
<person name="Borzym K."/>
<person name="Gardiner K."/>
<person name="Nizetic D."/>
<person name="Francis F."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Yaspo M.-L."/>
</authorList>
<dbReference type="PubMed" id="10830953"/>
<dbReference type="DOI" id="10.1038/35012518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="2048" last="2056">
<title>Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.</title>
<authorList>
<person name="Li X."/>
<person name="Leung S."/>
<person name="Kerr I.M."/>
<person name="Stark G.R."/>
</authorList>
<dbReference type="PubMed" id="9121453"/>
<dbReference type="DOI" id="10.1128/mcb.17.4.2048"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STAT1 AND STAT2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="255" first="539" last="544">
<title>Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation.</title>
<authorList>
<person name="Russell-Harde D."/>
<person name="Wagner T.C."/>
<person name="Perez H.D."/>
<person name="Croze E."/>
</authorList>
<dbReference type="PubMed" id="10049744"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.0105"/>
</citation>
<scope>INTERACTION WITH IFNAR1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="1493" last="1499">
<title>Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells.</title>
<authorList>
<person name="Wagner T.C."/>
<person name="Velichko S."/>
<person name="Vogel D."/>
<person name="Rani M.R."/>
<person name="Leung S."/>
<person name="Ransohoff R.M."/>
<person name="Stark G.R."/>
<person name="Perez H.D."/>
<person name="Croze E."/>
</authorList>
<dbReference type="PubMed" id="11682488"/>
<dbReference type="DOI" id="10.1074/jbc.m108928200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT TYR-337 AND TYR-512</scope>
<scope>MUTAGENESIS OF TYR-269; TYR-306; TYR-316; TYR-318; TYR-337; TYR-411 AND TYR-512</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="35635" last="35641">
<title>STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c. Activation of multiple STATS proceeds through the redundant usage of two tyrosine residues.</title>
<authorList>
<person name="Velichko S."/>
<person name="Wagner T.C."/>
<person name="Turkson J."/>
<person name="Jove R."/>
<person name="Croze E."/>
</authorList>
<dbReference type="PubMed" id="12105218"/>
<dbReference type="DOI" id="10.1074/jbc.m204578200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT TYR-337 AND TYR-512</scope>
<scope>MUTAGENESIS OF TYR-269; TYR-306; TYR-316; TYR-318; TYR-337; TYR-411 AND TYR-512</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-400</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Structure" volume="11" first="791" last="802">
<title>The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding.</title>
<authorList>
<person name="Chill J.H."/>
<person name="Quadt S.R."/>
<person name="Levy R."/>
<person name="Schreiber G."/>
<person name="Anglister J."/>
</authorList>
<dbReference type="PubMed" id="12842042"/>
<dbReference type="DOI" id="10.1016/s0969-2126(03)00120-5"/>
</citation>
<scope>STRUCTURE BY NMR OF 28-237</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="9148" last="9153">
<title>Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence.</title>
<authorList>
<person name="Frodsham A.J."/>
<person name="Zhang L."/>
<person name="Dumpis U."/>
<person name="Taib N.A.M."/>
<person name="Best S."/>
<person name="Durham A."/>
<person name="Hennig B.J.W."/>
<person name="Hellier S."/>
<person name="Knapp S."/>
<person name="Wright M."/>
<person name="Chiaramonte M."/>
<person name="Bell J.I."/>
<person name="Graves M."/>
<person name="Whittle H.C."/>
<person name="Thomas H.C."/>
<person name="Thursz M.R."/>
<person name="Hill A.V.S."/>
</authorList>
<dbReference type="PubMed" id="16757563"/>
<dbReference type="DOI" id="10.1073/pnas.0602800103"/>
</citation>
<scope>INVOLVEMENT IN SUSCEPTIBILITY TO HBV INFECTION</scope>
<scope>VARIANTS SER-8 AND VAL-10</scope>
<scope>CHARACTERIZATION OF VARIANT SER-8</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="Cell Rep." volume="5" first="180" last="193">
<title>A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses.</title>
<authorList>
<person name="Zheng H."/>
<person name="Gupta V."/>
<person name="Patterson-Fortin J."/>
<person name="Bhattacharya S."/>
<person name="Katlinski K."/>
<person name="Wu J."/>
<person name="Varghese B."/>
<person name="Carbone C.J."/>
<person name="Aressy B."/>
<person name="Fuchs S.Y."/>
<person name="Greenberg R.A."/>
</authorList>
<dbReference type="PubMed" id="24075985"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.08.025"/>
</citation>
<scope>INTERACTION WITH IFNAR1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Protein Sci." volume="15" first="2656" last="2668">
<title>Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.</title>
<authorList>
<person name="Quadt-Akabayov S.R."/>
<person name="Chill J.H."/>
<person name="Levy R."/>
<person name="Kessler N."/>
<person name="Anglister J."/>
</authorList>
<dbReference type="PubMed" id="17001036"/>
<dbReference type="DOI" id="10.1110/ps.062283006"/>
</citation>
<scope>STRUCTURE BY NMR OF 28-239 IN COMPLEX WITH IFNA2</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Biochemistry" volume="49" first="5117" last="5133">
<title>Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY.</title>
<authorList>
<person name="Nudelman I."/>
<person name="Akabayov S.R."/>
<person name="Schnur E."/>
<person name="Biron Z."/>
<person name="Levy R."/>
<person name="Xu Y."/>
<person name="Yang D."/>
<person name="Anglister J."/>
</authorList>
<dbReference type="PubMed" id="20496919"/>
<dbReference type="DOI" id="10.1021/bi100041f"/>
</citation>
<scope>STRUCTURE BY NMR OF 28-239 IN COMPLEX WITH IFNA2</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Cell" volume="146" first="621" last="632">
<title>Structural linkage between ligand discrimination and receptor activation by type I interferons.</title>
<authorList>
<person name="Thomas C."/>
<person name="Moraga I."/>
<person name="Levin D."/>
<person name="Krutzik P.O."/>
<person name="Podoplelova Y."/>
<person name="Trejo A."/>
<person name="Lee C."/>
<person name="Yarden G."/>
<person name="Vleck S.E."/>
<person name="Glenn J.S."/>
<person name="Nolan G.P."/>
<person name="Piehler J."/>
<person name="Schreiber G."/>
<person name="Garcia K.C."/>
</authorList>
<dbReference type="PubMed" id="21854986"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.06.048"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 28-436 IN COMPLEX WITH IFNAR1 AND IFNW1</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="J. Am. Chem. Soc." volume="133" first="14755" last="14764">
<title>Observation of intermolecular interactions in large protein complexes by 2D-double difference nuclear Overhauser enhancement spectroscopy: application to the 44 kDa interferon-receptor complex.</title>
<authorList>
<person name="Nudelman I."/>
<person name="Akabayov S.R."/>
<person name="Scherf T."/>
<person name="Anglister J."/>
</authorList>
<dbReference type="PubMed" id="21819146"/>
<dbReference type="DOI" id="10.1021/ja205480v"/>
</citation>
<scope>STRUCTURE BY NMR OF 28-237</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2015" name="Sci. Transl. Med." volume="7" first="307RA154" last="307RA154">
<title>Human IFNAR2 deficiency: Lessons for antiviral immunity.</title>
<authorList>
<person name="Duncan C.J."/>
<person name="Mohamad S.M."/>
<person name="Young D.F."/>
<person name="Skelton A.J."/>
<person name="Leahy T.R."/>
<person name="Munday D.C."/>
<person name="Butler K.M."/>
<person name="Morfopoulou S."/>
<person name="Brown J.R."/>
<person name="Hubank M."/>
<person name="Connell J."/>
<person name="Gavin P.J."/>
<person name="McMahon C."/>
<person name="Dempsey E."/>
<person name="Lynch N.E."/>
<person name="Jacques T.S."/>
<person name="Valappil M."/>
<person name="Cant A.J."/>
<person name="Breuer J."/>
<person name="Engelhardt K.R."/>
<person name="Randall R.E."/>
<person name="Hambleton S."/>
</authorList>
<dbReference type="PubMed" id="26424569"/>
<dbReference type="DOI" id="10.1126/scitranslmed.aac4227"/>
</citation>
<scope>INVOLVEMENT IN IMD45</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="13 14 15 22 24 25 26">Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation (PubMed:26424569). Isoform 1 and isoform 2 are directly involved in signal transduction due to their association with the TYR kinase, JAK1 (PubMed:8181059, PubMed:7665574, PubMed:7759950). Isoform 3 is a potent inhibitor of type I IFN receptor activity (PubMed:7759950).</text>
</comment>
<comment type="subunit">
<text evidence="13 17 18 20 21 24 25 26 27">Heterodimer with IFNAR1 (PubMed:8181059, PubMed:7665574, PubMed:10049744, PubMed:24075985, PubMed:21854986). Isoform 1 interacts with the transcriptional factors STAT1 and STAT2 (PubMed:9121453). Interacts with JAK1 (PubMed:8181059, PubMed:7759950).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-958408">
<id>P48551</id>
</interactant>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-958408">
<id>P48551</id>
</interactant>
<interactant intactId="EBI-626526">
<id>Q00978</id>
<label>IRF9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-958408">
<id>P48551</id>
</interactant>
<interactant intactId="EBI-1383438">
<id>P23458</id>
<label>JAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-958408">
<id>P48551</id>
</interactant>
<interactant intactId="EBI-296739">
<id>P63244</id>
<label>RACK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-958408">
<id>P48551</id>
</interactant>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-958408">
<id>P48551</id>
</interactant>
<interactant intactId="EBI-1546963">
<id>P52630</id>
<label>STAT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-958408">
<id>P48551</id>
</interactant>
<interactant intactId="EBI-356206">
<id>Q9UMW8</id>
<label>USP18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="24">Cell membrane</location>
<topology evidence="24">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="24 25 26">Cell membrane</location>
<topology evidence="24">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location evidence="25 26">Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P48551-1</id>
<name>1</name>
<name evidence="31">Long form beta</name>
<name>IFNaR2-2</name>
<name>IFNaR2-1b</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P48551-2</id>
<name>2</name>
<name evidence="31">Short form beta</name>
<name>IFNaR2-1</name>
<name>IFNaR2-1a</name>
<sequence type="described" ref="VSP_001738 VSP_001739"/>
</isoform>
<isoform>
<id>P48551-3</id>
<name>3</name>
<name>IFNaR2-3</name>
<name>IFNaR2-2a</name>
<name evidence="33">P40</name>
<sequence type="described" ref="VSP_001736 VSP_001737"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="23 25 26">Isoform 3 is detected in the urine (at protein level) (PubMed:8181059, PubMed:7759950). Expressed in blood cells. Expressed in lymphoblastoid and fibrosarcoma cell lines.</text>
</comment>
<comment type="PTM">
<text evidence="14 15 25">Phosphorylated on tyrosine residues upon interferon binding. Phosphorylation at Tyr-337 or Tyr-512 are sufficient to mediate interferon dependent activation of STAT1, STAT2 and STAT3 leading to antiproliferative effects on many different cell types.</text>
</comment>
<comment type="PTM">
<text evidence="26">Glycosylated.</text>
</comment>
<comment type="polymorphism">
<text>Genetic variations in IFNAR2 influence susceptibility to hepatitis B virus (HBV) infection [MIM:610424].</text>
</comment>
<comment type="disease" evidence="22">
<disease id="DI-04586">
<name>Immunodeficiency 45</name>
<acronym>IMD45</acronym>
<description>An autosomal recessive disorder characterized by increased susceptibility to viral infection due to impaired antiviral immunity, resulting in infection-associated encephalopathy. Affected individuals are at risk for developing fatal encephalitis after routine measles/mumps/rubella (MMR) vaccination.</description>
<dbReference type="MIM" id="616669"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="35">Soluble receptor.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the type II cytokine receptor family.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ifnar2/"/>
</comment>
<dbReference type="EMBL" id="X77722">
<property type="protein sequence ID" value="CAA54785.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L42243">
<property type="protein sequence ID" value="AAB46417.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42238">
<property type="protein sequence ID" value="AAB46417.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42239">
<property type="protein sequence ID" value="AAB46417.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42240">
<property type="protein sequence ID" value="AAB46417.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42323">
<property type="protein sequence ID" value="AAB46417.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42241">
<property type="protein sequence ID" value="AAB46417.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42242">
<property type="protein sequence ID" value="AAB46417.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42243">
<property type="protein sequence ID" value="AAB46418.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42238">
<property type="protein sequence ID" value="AAB46418.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42239">
<property type="protein sequence ID" value="AAB46418.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42240">
<property type="protein sequence ID" value="AAB46418.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42323">
<property type="protein sequence ID" value="AAB46418.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42241">
<property type="protein sequence ID" value="AAB46418.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42243">
<property type="protein sequence ID" value="AAB46419.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42238">
<property type="protein sequence ID" value="AAB46419.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42239">
<property type="protein sequence ID" value="AAB46419.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42240">
<property type="protein sequence ID" value="AAB46419.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42323">
<property type="protein sequence ID" value="AAB46419.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42241">
<property type="protein sequence ID" value="AAB46419.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L42242">
<property type="protein sequence ID" value="AAB46419.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L41942">
<property type="protein sequence ID" value="AAB46413.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L41943">
<property type="protein sequence ID" value="AAB46414.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L41944">
<property type="protein sequence ID" value="AAB46415.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U29584">
<property type="protein sequence ID" value="AAC50202.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X89814">
<property type="protein sequence ID" value="CAA61940.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X89772">
<property type="protein sequence ID" value="CAA61914.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY740397">
<property type="protein sequence ID" value="AAU21038.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK293059">
<property type="protein sequence ID" value="BAF85748.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR541817">
<property type="protein sequence ID" value="CAG46616.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000292">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000293">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000294">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000295">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471079">
<property type="protein sequence ID" value="EAX09842.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471079">
<property type="protein sequence ID" value="EAX09843.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471079">
<property type="protein sequence ID" value="EAX09844.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471079">
<property type="protein sequence ID" value="EAX09846.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13621.1">
<molecule id="P48551-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13622.1">
<molecule id="P48551-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74782.1">
<molecule id="P48551-3"/>
</dbReference>
<dbReference type="PIR" id="I39073">
<property type="entry name" value="I39073"/>
</dbReference>
<dbReference type="PIR" id="S59501">
<property type="entry name" value="S59501"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000865.2">
<molecule id="P48551-2"/>
<property type="nucleotide sequence ID" value="NM_000874.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276054.1">
<molecule id="P48551-1"/>
<property type="nucleotide sequence ID" value="NM_001289125.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276055.1">
<molecule id="P48551-3"/>
<property type="nucleotide sequence ID" value="NM_001289126.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276057.1">
<molecule id="P48551-3"/>
<property type="nucleotide sequence ID" value="NM_001289128.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_997467.1">
<molecule id="P48551-2"/>
<property type="nucleotide sequence ID" value="NM_207584.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_997468.1">
<molecule id="P48551-1"/>
<property type="nucleotide sequence ID" value="NM_207585.2"/>
</dbReference>
<dbReference type="PDB" id="1N6U">
<property type="method" value="NMR"/>
<property type="chains" value="A=28-237"/>
</dbReference>
<dbReference type="PDB" id="1N6V">
<property type="method" value="NMR"/>
<property type="chains" value="A=28-237"/>
</dbReference>
<dbReference type="PDB" id="2HYM">
<property type="method" value="NMR"/>
<property type="chains" value="A=28-237"/>
</dbReference>
<dbReference type="PDB" id="2KZ1">
<property type="method" value="NMR"/>
<property type="chains" value="B=28-237"/>
</dbReference>
<dbReference type="PDB" id="2LAG">
<property type="method" value="NMR"/>
<property type="chains" value="B=28-237"/>
</dbReference>
<dbReference type="PDB" id="3S8W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C=131-232"/>
</dbReference>
<dbReference type="PDB" id="3S9D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B/D=37-232"/>
</dbReference>
<dbReference type="PDB" id="3SE3">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="C=34-232"/>
</dbReference>
<dbReference type="PDB" id="3SE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="C=34-232"/>
</dbReference>
<dbReference type="PDBsum" id="1N6U"/>
<dbReference type="PDBsum" id="1N6V"/>
<dbReference type="PDBsum" id="2HYM"/>
<dbReference type="PDBsum" id="2KZ1"/>
<dbReference type="PDBsum" id="2LAG"/>
<dbReference type="PDBsum" id="3S8W"/>
<dbReference type="PDBsum" id="3S9D"/>
<dbReference type="PDBsum" id="3SE3"/>
<dbReference type="PDBsum" id="3SE4"/>
<dbReference type="BMRB" id="P48551"/>
<dbReference type="SMR" id="P48551"/>
<dbReference type="BioGRID" id="109677">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="CORUM" id="P48551"/>
<dbReference type="DIP" id="DIP-945N"/>
<dbReference type="IntAct" id="P48551">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="MINT" id="P48551"/>
<dbReference type="STRING" id="9606.ENSP00000343957"/>
<dbReference type="ChEMBL" id="CHEMBL2364170"/>
<dbReference type="DrugBank" id="DB00034">
<property type="generic name" value="Interferon alfa-2a, Recombinant"/>
</dbReference>
<dbReference type="DrugBank" id="DB00105">
<property type="generic name" value="Interferon alfa-2b"/>
</dbReference>
<dbReference type="DrugBank" id="DB00011">
<property type="generic name" value="Interferon alfa-n1"/>
</dbReference>
<dbReference type="DrugBank" id="DB00018">
<property type="generic name" value="Interferon alfa-n3"/>
</dbReference>
<dbReference type="DrugBank" id="DB00069">
<property type="generic name" value="Interferon alfacon-1"/>
</dbReference>
<dbReference type="DrugBank" id="DB00060">
<property type="generic name" value="Interferon beta-1a"/>
</dbReference>
<dbReference type="DrugBank" id="DB00068">
<property type="generic name" value="Interferon beta-1b"/>
</dbReference>
<dbReference type="DrugBank" id="DB06152">
<property type="generic name" value="Nylidrin"/>
</dbReference>
<dbReference type="DrugBank" id="DB05472">
<property type="generic name" value="omega interferon"/>
</dbReference>
<dbReference type="DrugBank" id="DB00008">
<property type="generic name" value="Peginterferon alfa-2a"/>
</dbReference>
<dbReference type="DrugBank" id="DB00022">
<property type="generic name" value="Peginterferon alfa-2b"/>
</dbReference>
<dbReference type="DrugCentral" id="P48551"/>
<dbReference type="GlyConnect" id="2051">
<property type="glycosylation" value="4 N-Linked glycans (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="P48551">
<property type="glycosylation" value="6 sites, 4 N-linked glycans (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="P48551"/>
<dbReference type="PhosphoSitePlus" id="P48551"/>
<dbReference type="BioMuta" id="IFNAR2"/>
<dbReference type="DMDM" id="1352466"/>
<dbReference type="jPOST" id="P48551"/>
<dbReference type="MassIVE" id="P48551"/>
<dbReference type="MaxQB" id="P48551"/>
<dbReference type="PaxDb" id="P48551"/>
<dbReference type="PeptideAtlas" id="P48551"/>
<dbReference type="PRIDE" id="P48551"/>
<dbReference type="ProteomicsDB" id="55905">
<molecule id="P48551-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55906">
<molecule id="P48551-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55907">
<molecule id="P48551-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="34938">
<property type="antibodies" value="375 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3455"/>
<dbReference type="Ensembl" id="ENST00000342101">
<molecule id="P48551-3"/>
<property type="protein sequence ID" value="ENSP00000343289"/>
<property type="gene ID" value="ENSG00000159110"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000342136">
<molecule id="P48551-1"/>
<property type="protein sequence ID" value="ENSP00000343957"/>
<property type="gene ID" value="ENSG00000159110"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000382264">
<molecule id="P48551-2"/>
<property type="protein sequence ID" value="ENSP00000371699"/>
<property type="gene ID" value="ENSG00000159110"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000404220">
<molecule id="P48551-2"/>
<property type="protein sequence ID" value="ENSP00000384309"/>
<property type="gene ID" value="ENSG00000159110"/>
</dbReference>
<dbReference type="GeneID" id="3455"/>
<dbReference type="KEGG" id="hsa:3455"/>
<dbReference type="UCSC" id="uc002yrb.5">
<molecule id="P48551-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3455"/>
<dbReference type="DisGeNET" id="3455"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000159110.19"/>
<dbReference type="GeneCards" id="IFNAR2"/>
<dbReference type="HGNC" id="HGNC:5433">
<property type="gene designation" value="IFNAR2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000159110">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="IFNAR2"/>
<dbReference type="MIM" id="602376">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="610424">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616669">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P48551"/>
<dbReference type="OpenTargets" id="ENSG00000159110"/>
<dbReference type="Orphanet" id="431166">
<property type="disease" value="Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29671"/>
<dbReference type="eggNOG" id="ENOG502S60E">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00510000049322"/>
<dbReference type="HOGENOM" id="CLU_072607_0_0_1"/>
<dbReference type="InParanoid" id="P48551"/>
<dbReference type="KO" id="K05131"/>
<dbReference type="OMA" id="TGDGYIM"/>
<dbReference type="OrthoDB" id="680035at2759"/>
<dbReference type="PhylomeDB" id="P48551"/>
<dbReference type="TreeFam" id="TF335897"/>
<dbReference type="PathwayCommons" id="P48551"/>
<dbReference type="Reactome" id="R-HSA-909733">
<molecule id="P48551-2"/>
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912694">
<molecule id="P48551-2"/>
<property type="pathway name" value="Regulation of IFNA signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P48551"/>
<dbReference type="SIGNOR" id="P48551"/>
<dbReference type="BioGRID-ORCS" id="3455">
<property type="hits" value="8 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IFNAR2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P48551"/>
<dbReference type="GeneWiki" id="IFNAR2"/>
<dbReference type="GenomeRNAi" id="3455"/>
<dbReference type="Pharos" id="P48551">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P48551"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 21"/>
</dbReference>
<dbReference type="RNAct" id="P48551">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000159110">
<property type="expression patterns" value="Expressed in blood and 241 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P48551">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P48551">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004896">
<property type="term" value="F:cytokine receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019962">
<property type="term" value="F:type I interferon binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004905">
<property type="term" value="F:type I interferon receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007259">
<property type="term" value="P:receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060338">
<property type="term" value="P:regulation of type I interferon-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035455">
<property type="term" value="P:response to interferon-alpha"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035456">
<property type="term" value="P:response to interferon-beta"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036116">
<property type="entry name" value="FN3_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR015373">
<property type="entry name" value="Interferon/interleukin_rcp_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF09294">
<property type="entry name" value="Interfer-bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01108">
<property type="entry name" value="Tissue_fac"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="26"/>
</location>
</feature>
<feature type="chain" description="Interferon alpha/beta receptor 2" id="PRO_0000011006">
<location>
<begin position="27"/>
<end position="515"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="12">
<location>
<begin position="27"/>
<end position="243"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="12">
<location>
<begin position="244"/>
<end position="264"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="12">
<location>
<begin position="265"/>
<end position="515"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="14 15">
<location>
<position position="337"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="400"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="467"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="14 15">
<location>
<position position="512"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="58"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="26">
<location>
<position position="87"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="116"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12">
<location>
<position position="188"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="26">
<location>
<position position="192"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 4 5 7 8 9 17 18 19 20">
<location>
<begin position="39"/>
<end position="122"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 4 5 7 8 9 17 18 19 20">
<location>
<begin position="85"/>
<end position="93"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 4 5 6 7 8 9 17 18 19 20">
<location>
<begin position="207"/>
<end position="227"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_001736" evidence="30 32">
<original>SA</original>
<variation>FS</variation>
<location>
<begin position="238"/>
<end position="239"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_001737" evidence="30 32">
<location>
<begin position="240"/>
<end position="515"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_001738" evidence="30 33 34">
<original>NFHNFLAWPFPNLPPLEAMDMVEVIYINRKKKVWDYNYDDESDSDTEAAPR</original>
<variation>RQGLAKGWNAVAIHRCSHNALQSETPELKQSSCLSFPSSWDYKRASLCPSD</variation>
<location>
<begin position="281"/>
<end position="331"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_001739" evidence="30 33 34">
<location>
<begin position="332"/>
<end position="515"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with susceptibility to HVB infection; lower cell surface levels; lower induction of MHC class 1 expression by INF-alpha; dbSNP:rs2229207." id="VAR_020521" evidence="16 29">
<original>F</original>
<variation>S</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1051393." id="VAR_020522" evidence="16 25 26 28 29">
<original>F</original>
<variation>V</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17860223." id="VAR_020523" evidence="29">
<original>I</original>
<variation>V</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit STAT1, STAT2 and STAT3 activation by IFN. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-306; F-316; F-318; F-337; F-411 and F-512. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-306; F-316; F-318; F-411 and F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-306; F-316; F-318 and F-337." evidence="14 15">
<original>Y</original>
<variation>F</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit STAT1, STAT2 and STAT3 activation by IFN. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-316; F-318; F-337; F-411 and F-512. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-316; F-318; F-411 and F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-316; F-318 and F-337." evidence="14 15">
<original>Y</original>
<variation>F</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit STAT1, STAT2 and STAT3 activation by IFN. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-318; F-337; F-411 and F-512. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-318; F-411 and F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-318 and F-337." evidence="14 15">
<original>Y</original>
<variation>F</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit STAT1, STAT2 and STAT3 activation by IFN. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316; F-337; F-411 and F-512. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316; F-411 and F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316 and F-337." evidence="14 15">
<original>Y</original>
<variation>F</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit STAT1, STAT2 and STAT3 activation by IFN. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316; F-318; F-411 and F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316 and F-318." evidence="14 15">
<original>Y</original>
<variation>F</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit STAT1, STAT2 and STAT3 activation by IFN. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316; F-318; F-337 and F-512. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316; F-318 and F-512. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-512." evidence="14 15">
<original>Y</original>
<variation>F</variation>
<location>
<position position="411"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit STAT1, STAT2 and STAT3 activation by IFN. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316; F-318; F-337 and F-411. Inhibits STAT1, STAT2 and STAT3 activation by IFN; when associated with F-269; F-306; F-316; F-318 and F-411. Does not inhibit STAT1, STAT2 and STAT3 activation by IFN; when associated with F-411." evidence="14 15">
<original>Y</original>
<variation>F</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC50202." ref="3" evidence="35">
<original>M</original>
<variation>V</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="40"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="49"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="59"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="65"/>
<end position="75"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="83"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="86"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="91"/>
<end position="94"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="96"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="102"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="106"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="119"/>
<end position="126"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="128"/>
<end position="131"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="138"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="148"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="167"/>
<end position="174"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="177"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="186"/>
<end position="188"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="191"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="205"/>
<end position="213"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="226"/>
<end position="229"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N6U"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N6V"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2HYM"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KZ1"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LAG"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3S8W"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3S9D"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SE3"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SE4"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O35664"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10049744"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11682488"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12105218"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16757563"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17001036"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20496919"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21819146"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21854986"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24075985"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26424569"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7588638"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7665574"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7759950"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8181059"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9121453"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="29" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7588638"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7665574"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7759950"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8181059"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source ref="8"/>
</evidence>
<evidence key="35" type="ECO:0000305"/>
<sequence length="515" mass="57759" checksum="4D7730D93AA739F4" modified="1996-02-01" version="1" precursor="true">MLLSQNAFIFRSLNLVLMVYISLVFGISYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLKVVKNCANTTRSFCDLTDEWRSTHEAYVTVLEGFSGNTTLFSCSHNFWLAIDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKGNMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPPGQESESAESAKIGGIITVFLIALVLTSTIVTLKWIGYICLRNSLPKVLNFHNFLAWPFPNLPPLEAMDMVEVIYINRKKKVWDYNYDDESDSDTEAAPRTSGGGYTMHGLTVRPLGQASATSTESQLIDPESEEEPDLPEVDVELPTMPKDSPQQLELLSGPCERRKSPLQDPFPEEDYSSTEGSGGRITFNVDLNSVFLRVLDDEDSDDLEAPLMLSSHLEEMVDPEDPDNVQSNHLLASGEGTQPTFPSPSSEGLWSEDAPSDQSDTSESDVDLGDGYIMR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

